This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ARTHUR BERNSTEIN, M.D.; FRANKLIN SIMON, M.D.

AMA Arch Intern Med. 1959;103(6):954-956.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The wide diversity of usefulness of chlorpromazine* in clinical practice is too well known to review in this paper. Suffice it to say, it has found widespread acceptance because of its profound antiemetic effect, its ability to potentiate narcotics and sedatives, and most of all, its capacity to alleviate anxiety, agitation, and tension states. Dosage has varied tremendously, and complications have been noted at all dosage levels and at all durations of therapy.

We are primarily interested in the production of jaundice as a complication of chlorpromazine therapy, which has been reported in as low as 0.2% ¹ and as high as 5% of patients,² with an average of 1.26% ³ (103 cases of jaundice in 8,127 treated cases). Histologic and biochemical data indicate a picture which mimics extrahepatic obstruction: An elevation of the serum alkaline phosphatase, serum cholesterol, and serum bilirubin, with little or no disturbance of the . . . [Full Text PDF of this Article]

Author Affiliations
Newark, N. J.

Footnotes
Submitted for publication Aug. 28, 1958.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?